MedTrace Logo

Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy

NCT03889951 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-03-26

No results posted yet for this study

Summary

1. To detect IKZF-1 deletion mutations in patients with ALL.
2. To study the impact of IKZF-1 deletion mutation on therapy of ALL.
3. To study the correlation between IKZF-1 deletion mutations and BCR-ABL.

Conditions

  • ALL, Childhood

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
1 Year
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-30
Primary Completion
2020-04-30
Completion
2020-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03889951 on ClinicalTrials.gov